日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

特拉洛奇尤单抗治疗中重度特应性皮炎成人患者的疗效和安全性：III期试验的事后分析

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00985-1
Mayo, Tiffany; Silverberg, Jonathan I; Armstrong, April; Guttman-Yassky, Emma; Blauvelt, Andrew; Esdaile, Ben; Kabashima, Kenji; Gooderham, Melinda; Kircik, Leon; Schneider, Shannon; Bennike, Niels; von Eyben, Rie; Martel, Britta C; Røpke, Mads A; Katoh, Norito; Alexis, Andrew F
发表日期：2026
文献求助 收藏

Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis

tralokinumab治疗中重度特应性皮炎成人患者长达4年的疗效

期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.70165
Gooderham, Melinda; Ameen, Mahreen; Hong, H Chih-Ho; Katoh, Norito; Langley, Richard G; Peris, Ketty; Reich, Kristian; Silvestre, Juan F; Simpson, Eric; Werfel, Thomas; Gjerum, Le; Tindberg, Ann-Marie; Øland, Christian Bjerregård; Blauvelt, Andrew
发表日期：2026
文献求助 收藏

Cutaneous adipose tissue carries a strong inflammatory signature in patients with psoriasis

银屑病患者的皮肤脂肪组织具有强烈的炎症特征。

期刊:JCI Insight
影响因子:6.1
doi:10.1172/jci.insight.194171
Shishido-Takahashi, Naomi; Garcet, Sandra; Cueto, Inna; Hur, Hong Beom; Muscianisi, Elisa; Steadman, Jennifer; Blauvelt, Andrew; Krueger, James G
炎症/感染
炎症
银屑病
发表日期：2026
文献求助 收藏

High-Dose, Extended Half-Life IL-23 Inhibitors: the Next Big Step in Psoriasis Care?

高剂量、长半衰期IL-23抑制剂：银屑病治疗的下一个重大进展？

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-026-01707-z
Torres, Tiago; Blauvelt, Andrew
IL-2
IL-23
银屑病
发表日期：2026
文献求助 收藏

Poster Session I - A110 TRENDS IN SPENDING ON ADVANCED IBD THERAPIES PRESCRIBED BY GASTROENTEROLOGISTS IN MEDICARE

海报展示环节 I - A110 医疗保险中胃肠病学家开具的先进炎症性肠病 (IBD) 疗法支出趋势

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-022-00690-5
Blauvelt, Andrew; Gooderham, Melinda; Griffiths, Christopher E M; Armstrong, April W; Zhu, Baojin; Burge, Russel; Gallo, Gaia; Guo, Jiaying; Garrelts, Alyssa; Lebwohl, Mark; Raber, M; Lu, C; Ma, C; Nasser, Y; Congly, S
炎症
炎症/感染
发表日期：2026
文献求助 收藏

A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study

对 Amlitelimab STREAM-AD 2b 期研究中头颈部及其他身体部位特应性皮炎的事后分析

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01609-6
Reich, Adam; Blauvelt, Andrew; Weidinger, Stephan; Shi, Vivian Y; Katoh, Norito; Lynde, Charles; Gao, Xinghua; Armstrong, Nicole M; Bernigaud, Charlotte; Rahawi, Kassim
发表日期：2026
文献求助 收藏

Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies

鲁索替尼乳膏按需单药治疗在轻度至中度特应性皮炎患者中显示出持续的疾病和症状控制：两项3期研究的汇总分析

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01639-0
Blauvelt, Andrew; Kircik, Leon; Simpson, Eric L; Lio, Peter; Eichenfield, Lawrence F; Prajapati, Vimal H; Grewal, Parbeer; Lynde, Charles; Hong, H Chih-Ho; Sturm, Daniel; Kallender, Howard; Ren, Haobo; Paranagama, Dilan; Wong, Grace K W; Geng, Bob
发表日期：2026
文献求助 收藏

Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND

特拉洛奇尤单抗治疗中重度特应性皮炎患者长达6年的长期安全性和有效性：开放标签扩展试验ECZTEND的最终结果

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-026-01656-7
Blauvelt, Andrew; Hong, H Chih-Ho; Katoh, Norito; Langley, Richard G; Laquer, Vivian; Lesiak, Aleksandra; Peris, Ketty; Seneschal, Julien; Silvestre, Juan-Francisco; Warren, Richard B; Wollenberg, Andreas; Zirwas, Matthew; Bennike, Niels Højsager; Safavimanesh, Farzaneh; Tindberg, Ann-Marie; Reich, Kristian
发表日期：2026
文献求助 收藏

Psychometric Evaluation of Worst Pruritus Numeric Rating Scale in Adults With Moderate-to-Severe Atopic Dermatitis

对中重度特应性皮炎成人患者最严重瘙痒数字评分量表进行心理测量学评价

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01635-4
Blauvelt, Andrew; Williams, Angela; Deininger, Kimberly M; Qin, Shanshan; Nelson, Lauren; McLeod, Lori
发表日期：2026
文献求助 收藏

Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study

利布利珠单抗可改善既往接受过度普利尤单抗治疗的中重度特应性皮炎患者的临床表现、症状和生活质量：ADapt 研究结果

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01644-3
Silverberg, Jonathan I; Ackerman, Lindsay; Bagel, Jerry; Stein Gold, Linda; Blauvelt, Andrew; Rosmarin, David; Chovatiya, Raj; Zirwas, Matthew; Yosipovitch, Gil; Waibel, Jill; Murase, Jenny E; Lockshin, Ben; Weisman, Jamie; Atwater, Amber Reck; Proper, Jennifer; Silk, Maria; Pierce, Evangeline; Piruzeli, Maria Lucia Buziqui; Montmayeur, Sonia; Schuster, Christopher; Zhong, Jinglin; Rueda, Maria Jose; Pillai, Sreekumar; Simpson, Eric
发表日期：2026
文献求助 收藏